Show simple item record

The Established Status Epilepticus Trial 2013

dc.contributor.authorBleck, Thomasen_US
dc.contributor.authorCock, Hannahen_US
dc.contributor.authorChamberlain, Jamesen_US
dc.contributor.authorCloyd, Jamesen_US
dc.contributor.authorConnor, Jasonen_US
dc.contributor.authorElm, Jordanen_US
dc.contributor.authorFountain, Nathanen_US
dc.contributor.authorJones, Elizabethen_US
dc.contributor.authorLowenstein, Danielen_US
dc.contributor.authorShinnar, Shlomoen_US
dc.contributor.authorSilbergleit, Roberten_US
dc.contributor.authorTreiman, Daviden_US
dc.contributor.authorTrinka, Eugenen_US
dc.contributor.authorKapur, Jaideepen_US
dc.date.accessioned2013-09-04T17:18:35Z
dc.date.available2014-10-06T19:17:42Zen_US
dc.date.issued2013-09en_US
dc.identifier.citationBleck, Thomas; Cock, Hannah; Chamberlain, James; Cloyd, James; Connor, Jason; Elm, Jordan; Fountain, Nathan; Jones, Elizabeth; Lowenstein, Daniel; Shinnar, Shlomo; Silbergleit, Robert; Treiman, David; Trinka, Eugen; Kapur, Jaideep (2013). "The Established Status Epilepticus Trial 2013." Epilepsia : 89-92. <http://hdl.handle.net/2027.42/99653>en_US
dc.identifier.issn0013-9580en_US
dc.identifier.issn1528-1167en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/99653
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherLevetiracetamen_US
dc.subject.otherComparative Efficacyen_US
dc.subject.otherBayesian Designen_US
dc.subject.otherFosphenytoinen_US
dc.subject.otherValproic Aciden_US
dc.titleThe Established Status Epilepticus Trial 2013en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid24001084en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/99653/1/epi12288.pdf
dc.identifier.doi10.1111/epi.12288en_US
dc.identifier.sourceEpilepsiaen_US
dc.identifier.citedreferenceLoddenkemper T, Goodkin HP. ( 2011 ) Treatment of pediatric status epilepticus. Curr Treat Options Neurol 13: 560 – 573.en_US
dc.identifier.citedreferenceDeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. ( 1995 ) Epidemiology of status epilepticus. J Clin Neurophysiol 12: 316 – 325.en_US
dc.identifier.citedreferenceConnor JT, Elm JJ, Broglio KR; ESETT and ADAPT‐IT Investigators. ( 2013 ) Bayesian adaptive trials for comparative effectiveness research: an example in status epilepticus. J Clin Epidemiol 66 (Suppl. 8): S130 – S137. In Press.en_US
dc.identifier.citedreferenceBrophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. ( 2012 ) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17: 3 – 23.en_US
dc.identifier.citedreferenceAlvarez V, Januel JM, Burnand B, Rossetti AO. ( 2011 ) Second‐line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 52: 1292 – 1296.en_US
dc.identifier.citedreferenceAlldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH. ( 2001 ) A comparison of lorazepam, diazepam, and placebo for the treatment of out‐of‐hospital status epilepticus. N Engl J Med 345: 631 – 637.en_US
dc.identifier.citedreferenceTowne AR. ( 2007 ) Epidemiology and outcomes of status epilepticus in the elderly. Int Rev Neurobiol 81: 111 – 127.en_US
dc.identifier.citedreferenceSilbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W; NETT Investigators. ( 2012 ) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 366: 591 – 600.en_US
dc.identifier.citedreferenceShinnar S, Bello JA, Chan S, Hesdorffer DC, Lewis DV, Macfall J, Pellock JM, Nordli DR, Frank LM, Moshe SL, Gomes W, Shinnar RC, Sun S; FEBSTAT Study Team. ( 2012 ) MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 79: 871 – 877.en_US
dc.identifier.citedreferenceShinnar S, Pellock JM, Moshé SL, Maytal J, O'Dell C, Driscoll SM, Alemany M, Newstein D, DeLorenzo RJ. ( 1997 ) In whom does status epilepticus occur: age‐related differences in children. Epilepsia 38: 907 – 914.en_US
dc.identifier.citedreferenceNordli DR Jr, Moshé SL, Shinnar S, Hesdorffer DC, Sogawa Y, Pellock JM, Lewis DV, Frank LM, Shinnar RC, Sun S; FEBSTAT Study Team. ( 2012 ) Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study. Neurology 79: 2180 – 2186.en_US
dc.identifier.citedreferenceNeligan A, Shorvon SD. ( 2010 ) Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol 67: 931 – 940.en_US
dc.identifier.citedreferenceMeierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, Holtkamp M. ( 2010 ) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17: 348 – 355.en_US
dc.identifier.citedreferenceDeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D. ( 1996 ) A prospective, population‐based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46: 1029 – 1035.en_US
dc.identifier.citedreferenceTreiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. ( 1998 ) A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339: 792 – 798.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.